Related Experiment Videos

Treatment of melancholia with tranylcypromine

P J McGrath, F M Quitkin, W Harrison

The American Journal of Psychiatry

|February 1, 1984

Abstract:

Nine of 12 outpatients meeting DSM-III criteria for melancholia responded to treatment with the monoamine oxidase inhibitor (MAOI) tranylcypromine. Responders were less depressed before treatment and after treatment than were nonresponders. MAOIs appear useful in treating endogenous depressions.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Human continuous glucose monitors for measurement of glucose in dairy cows.

JDS communications·2022

Comparison of production-related responses to hyperinsulinemia and hypoglycemia induced by clamp procedures or heat stress of lactating dairy cattle.

Journal of dairy science·2022

The effects on children of depressed mothers' remission and relapse over 9 months.

Psychological medicine·2014

Bioavailability of organic and inorganic phosphates adsorbed on short-range ordered aluminum precipitate.

Microbial ecology·2013

Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2010

Predictors of therapeutic response to treatments for depression: a review of electrophysiologic and dichotic listening studies.

CNS spectrums·2007

See all related articles